In addition, oral B401 treatment may have neuroprotective effects on the brain of 3× Tg-AD mice via increasing expressions of BDNF, VEGF, and antioxidative SOD2, while suppressing ROS production and reducing expressions of Aβ, p-Tau, NFTs, and oxidation-related 3-NT. This evidence concerns the gene VEGFA and Alzheimer disease.